CellaVision AB (publ) (STO:CEVI)
155.40
-2.60 (-1.65%)
Jan 21, 2026, 12:21 PM CET
CellaVision AB Market Cap
CellaVision AB has a market cap or net worth of 3.77 billion as of January 21, 2026. Its market cap has decreased by -27.36% in one year.
Market Cap
3.77B
Enterprise Value
3.64B
Revenue
748.45M
Ranking
n/a
PE Ratio
24.89
Stock Price
155.40
Market Cap Chart
Since May 28, 2007, CellaVision AB's market cap has increased from 372.09M to 3.77B, an increase of 912.80%. That is a compound annual growth rate of 13.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 19, 2026 | 3.72B | -0.76% |
| Dec 30, 2025 | 3.75B | -27.72% |
| Dec 30, 2024 | 5.19B | 2.59% |
| Dec 29, 2023 | 5.06B | -7.42% |
| Dec 30, 2022 | 5.46B | -29.58% |
| Dec 30, 2021 | 7.76B | 5.93% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 114.29B |
| Getinge AB | 60.57B |
| BioArctic AB | 48.85B |
| Sectra AB | 44.35B |
| Camurus AB | 41.24B |
| Medicover AB | 31.93B |
| Asker Healthcare Group AB | 30.15B |
| Elekta AB | 24.17B |